000			03017nam a22003017a 4500
001			20241022103534.0
003			OCoLC
005			20241022104132.0
008			241022b |||||||| |||| 00| 0 eng d
028			_b Wurzburg Road 35, Premises, Post Code: 33102 |
028			_b P. O. Box 1464 Mwanza, Tanzania |
028			_b Phone: (255) 28-298-3384 |
028			_bFax: (255) 28-298-3386 |
028			_bEmail: vc@bugando.ac.tz |
035			_aWebsite: www.bugando.ac.tz.
040			_cddc
041			_aEnglish
041			_aKiswahili
100			_e CUHAS/BP/3001178/T/20 _qJacquline Joseph Chuwa
245			_aAccess, utilization of supportive care medicines and management outcomes of chemotherapy induced toxicity among paediatric cancer patients at Bugando Medical Centre.
260			_a Mwanza, Tanzania | _b Catholic University of Health and Allied Sciences [CUHAS-Bugando] | _c2024.
300			_aIncludes References
520			_a "Abstract Background: Paediatric cancer is one of the non-communicable diseases, whose main intervention is chemotherapy. Chemotherapies causes  induced toxicities which in turn are reduced by the use of supportive care medicines. This study aimed to assess the access, utilization of supportive care medicines and management outcomes of chemotherapy induced toxicities. Methodology: This was descriptive cross-sectional study conducted among 120 paediatric cancer patients on chemotherapy, at Bugando Medical Centre from 1st to 28th April 2024. Data was collected using a semi-structured questionnaire then entered and cleaned in Microsoft excel 2019, followed by analysis using STATA version 15 then presented in frequency tables and figures. Results: A total of 120 (61 female and 59 male) paediatric cancer patients receiving chemotherapy and supportive care medicines were included in the study. Generally, the access of supportive care medicines was found to be poor access in (68.33%) compared to good access in  (31.6%) participants. Utilization in the other hand was found to be good (99.17%) and poor (0.83%). Majority of the patient (62.50%) reported to have experienced good resolution of chemotherapy induced toxicities upon the use of supportive care medicines compared to few (37.50%) who reported failure to continue with normal life routine due to chemotherapy induced toxicities. Conclusion: Access to supportive care medicines was poor due to financial difficult issues. On the other hand, utilization was good due to patient’s adherence to doctors’ directives. Outcome of management of chemotherapy induced toxicities was reported to be good among the majority due to the utilization of supportive care medicines."
600			_x Pharmaceutics and Pharmacy Practice
700			_qDeogratias Mwombeki Katabalo
856			_z Research Report Submitted in Partial Fulfilment for The Award of Bachelor of Pharmacy Degree of The Catholic University of Health and Allied Sciences.
942			_2ddc _cCR _n0
999			_c29268 _d29268